Marta Carol
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Marked Variation in Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease Over 5 Years: A Community-Based Study Using Controlled Attenuation Parameter.
Journal: United European gastroenterology journal
Published: March 21, 2025
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.
Journal: JAMA
Published: February 05, 2025
Liver fibrosis screening increases alcohol abstinence.
Journal: JHEP reports : innovation in hepatology
Published: January 25, 2024
Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.
Journal: Journal of hepatology
Published: September 14, 2023
Alcoholic Foamy Degeneration, an Entity Resembling Alcohol-Associated Hepatitis: Diagnosis, Prognosis, and Molecular Profiling.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: August 16, 2023
Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
Journal: BMC public health
Published: May 22, 2023
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study.
Journal: Lancet (London, England)
Published: December 19, 2022
Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcome.
Journal: Hepatology communications
Published: November 09, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.
Journal: Hepatology communications
Published: May 28, 2021
Last Updated: 09/26/2026